Table 2.
Characteristic of patients with RHCC.
| Study | The first treatment | Treatment | Tumor size (cm) | Tumor number (1/>1) | Child-pugh’ score (A/B) | Time to first recurrence (months) |
|---|---|---|---|---|---|---|
| Ueno 10 | Resection | RFA | 1.8(1.0–2.4) | 10/0 | 7/3 | 30(16–60) |
| TACE | 1.9(1.2–2.8) | 13/0 | 11/2 | 29(9–49) | ||
| Qkuwaki 11 | RFA | RFA | 1.6±0.6 | NA | 23/7 | 23.6 ± 13.7 |
| TACE | 1.4±0.4 | NA | 11/8 | 21.4 ± 14.4 | ||
| Koh 12 | Resection | RFA | 2.0(1.0–4.9) | 31/11 | 39/3 | 8.92(1.48–83.31) |
| TACE | 1.5(0.5–4.5) | 35/20 | 60/0 | 5.92(0.85–58.10) | ||
| Chen 13 | Resection | RFA | 1.9±0.6 | 22/6 | 30/2 | 17.6±15.4 |
| TACE | 1.9±1.0 | 55/23 | 75/3 | 9.7±21.5 | ||
| Kim 14 | Transplantation | RFA | 1.8(1.1–3.0) | 6/0 | NA | 27.7(11.8–38.6) |
| TACE | 1.4(1.6–7.7) | 21/0 | NA | 19.0(3.5–108.7) | ||
| Joliat 15 | Resection | RFA | NA | NA | NA | NA |
| TACE | NA | NA | NA | NA | ||
| Wang 16 | RFA | RFA | 2.18 ± 0.5 | 33/14 | 39/8 | 10.76 |
| TACE | 2.08 ± 0.5 | 17/15 | 25/7 | 10.04 | ||
| Kim 17 | Resection | RFA | 1.4(0.2–4.8) | 170/1 | 171/0 | 18(1–85) |
| TACE | 1.3(0.5–4.1) | 228/2 | 230/0 | 13.5(1–116) | ||
| Wang 18 | Resection | RFA | 2.3 ± 0.7 | 107/55 | NA | NA |
| TACE | 2.2 ± 0.9 | 204/135 | NA | NA |
RFA, radiofrequency ablation; TACE, transarterial chemoembolization; NA, not applicable.